| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.05 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |